UNIMYET
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Jan 2026)
What this means for you
This application is over — abandoned 26 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98454125
- Mark type
- Stylized text
- Filed
- 18 Mar 2024
- Published for opposition
- 12 Nov 2024
- Abandoned
- 26 Jan 2026
- Attorney of record
- Enshan Hong
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes for the treatment of cancer, autoimmune, and infectious diseases; biochemical medicines for the treatment of cancer, autoimmune, and infectious diseases; biological preparations for medical purposes for the treatment of cancer, autoimmune, and infectious diseases; pharmaceutical preparations for the treatment of autoimmune disorders, cancer, and infection; tumor suppressing agents; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer, autoimmune, and infectious diseases
Owner
- LTZ Therapeutics Inc., Redwood City, CA, US
- LTZ Therapeutics Inc., Redwood City, CA, US
Prosecution history
- 26 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Apr 2025 — SOU EXTENSION 1 GRANTED
- 07 Apr 2025 — SOU EXTENSION 1 FILED
- 07 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2024 — PUBLISHED FOR OPPOSITION
- 23 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Sept 2024 — ASSIGNED TO EXAMINER
- 02 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Mar 2024 — NEW APPLICATION ENTERED